Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Castle

Showing results (371-380 of 507) with videos related to

Pageof 51
Sort By:
Plos One|December 25, 2013
Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and genderDebra L Foley, Andrew Mackinnon, Gerald F Watts, et al.
Annals of Emergency Medicine|October 18, 2016
Midazolam-Droperidol, Droperidol, or Olanzapine for Acute Agitation: A Randomized Clinical TrialDavid McD Taylor, Celene Y L Yap, Jonathan C Knott, et al.
Annals of Emergency Medicine|March 25, 2017
In replyDavid M Taylor, Celene Y L Yap, David C M Kong, et al.
The Australian and New Zealand Journal of Psychiatry|January 15, 2015
Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sampleDebra L Foley, Andrew Mackinnon, Vera A Morgan, et al.
Nephrology (Carlton, Vic.)|January 23, 2021
A psychosocial intervention for individuals with advanced chronic kidney disease: A feasibility randomized controlled trialZoe M Jenkins, Eric J Tan, Emmet O'Flaherty, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|June 18, 2026
Concerns About Self-Safety or Own Emotional Regulation in the Home are Both Associated With Suicidal Ideation: A Risk Factor Warranting Research and Policy AttentionJames N Peak, Christopher T K Yuen, Denny Meyer, et al.
Neurology and Therapy|October 7, 2025
The Use of Long-Acting Injectables for People with Schizophrenia: Consensus Panel Recommendations for Overcoming Barriers and Implementing TreatmentJohn M Kane, Ofer Agid, David J Castle, et al.
The Medical Journal of Australia|May 6, 2011
Psychological distress (depression and anxiety) in people with head and neck cancersKate A Neilson, Annabel C Pollard, Ann M Boonzaier, et al.
Bjpsych Open|July 25, 2023
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialMuhammad Ishrat Husain, Daniel M Blumberger, David J Castle, et al.
Trials|September 11, 2016
The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trialCasey L O'Brien, Chantal F Ski, David R Thompson, et al.
Pageof 51

Showing results (371-380 of 507) with videos related to

Sort By:
Pageof 51
Plos One|December 25, 2013
Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and genderDebra L Foley, Andrew Mackinnon, Gerald F Watts, et al.
Annals of Emergency Medicine|October 18, 2016
Midazolam-Droperidol, Droperidol, or Olanzapine for Acute Agitation: A Randomized Clinical TrialDavid McD Taylor, Celene Y L Yap, Jonathan C Knott, et al.
Annals of Emergency Medicine|March 25, 2017
In replyDavid M Taylor, Celene Y L Yap, David C M Kong, et al.
The Australian and New Zealand Journal of Psychiatry|January 15, 2015
Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sampleDebra L Foley, Andrew Mackinnon, Vera A Morgan, et al.
Nephrology (Carlton, Vic.)|January 23, 2021
A psychosocial intervention for individuals with advanced chronic kidney disease: A feasibility randomized controlled trialZoe M Jenkins, Eric J Tan, Emmet O'Flaherty, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|June 18, 2026
Concerns About Self-Safety or Own Emotional Regulation in the Home are Both Associated With Suicidal Ideation: A Risk Factor Warranting Research and Policy AttentionJames N Peak, Christopher T K Yuen, Denny Meyer, et al.
Neurology and Therapy|October 7, 2025
The Use of Long-Acting Injectables for People with Schizophrenia: Consensus Panel Recommendations for Overcoming Barriers and Implementing TreatmentJohn M Kane, Ofer Agid, David J Castle, et al.
The Medical Journal of Australia|May 6, 2011
Psychological distress (depression and anxiety) in people with head and neck cancersKate A Neilson, Annabel C Pollard, Ann M Boonzaier, et al.
Bjpsych Open|July 25, 2023
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialMuhammad Ishrat Husain, Daniel M Blumberger, David J Castle, et al.
Trials|September 11, 2016
The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trialCasey L O'Brien, Chantal F Ski, David R Thompson, et al.
Pageof 51